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Abstract
NK cells provide a vital surveillance against virally infected cells, tumor cells, and antibody-
coated cells through the release of cytolytic mediators and gamma interferon (IFN-γ). 
Hexabromocyclododecane (HBCD) is a brominated flame retardant used primarily in expanded 
(EPS) and extruded (XPS) polystyrene foams for thermal insulation in the building and 
construction industry. Tetrabromobisphenol A (TBBPA) is used both as a reactive and an additive 
flame retardant in a variety of materials. HBCD and TBBPA contaminate the environment and are 
found in human blood samples. In previous studies, we have shown that other environmental 
contaminants, such as the dibutyltin (DBT) and tributyltin (TBT), decrease NK lytic function by 
activating mitogen-activated protein kinases (MAPKs) in the NK cells. HBCD and TBBPA also 
interfere with NK cell(s) lytic function. The current study evaluates whether HBCD and/or 
TBBPA have the capacity to activate MAPKs and MAPK kinases (MAP2Ks). The effects of 
concentrations of HBCD and TBBPA that inhibited lytic function on the phosphorylation state and 
total levels of the MAPKs (p44/42, p38, and JNK) and the phosphorylation and total levels of the 
MAP2Ks (MEK1/2 and MKK3/6) were examined. Results indicate that exposure of human NK 
cells to 10-0.5 µM HBCD or TBBPA activate MAPKs and MAP2Ks. This HBCD and TBBPA-
induced activation of MAPKs may leave them unavailable for activation by virally infected or 
tumor target cells and thus contributes to the observed decreases in lytic function seen in NK cells 
exposed to HBCD and TBBPA.
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Human NK cells are involved in the prevention of tumor development and viral infection 
due to their capacity to lyse mutated or infected cells and secrete cytokines (Lotzova, 1993). 
NK cells are a crucial immune defense against malignant neoplasms and viral infections 
(Lotzova, 1993; Vivier et al., 2004). Their role in protecting against cancers and viral 
infections is demonstrated by increased incidence of neoplasm and viral infection in 
individuals that lack NK cells (Ballas et al. 1990; Fleisher et al., 1982; Biron et al., 1989).
Mitogen activated protein kinases (MAPKs) and their upstream activators MAPK kinases 
(MAP2Ks) and MAP2K kinases (MAP3K) are part of the signaling pathways that regulate 
the function of human natural killer (NK) cells. The MAPK, p44/42 has been shown to be 
required for NK lysis of tumor target cells (Trotta et al., 1998; Vivier et al., 2004)), while 
both p44/42 and p38 activation appear to be needed for the secretion of cytokines (tumor 
necrosis factor alpha (TNFα) and interferon gamma (IFNγ) (Trotta et al., 1998; Trotta et al., 
2000).
Hexabromocyclododecane (HBCD) and tetrabomobisphenol A (TBBPA) are widely used 
brominated flame retardants. TBBPA is used in plastics, paper, and textiles as a flame 
retardant (HSBD, 2001; IPCS/WHO, 1995). Human exposure occurs by inhalation, dermal 
contact, and ingestion (Birnbaum and Staskal, 2004; Peterman et al., 2000; HSBD, 2001; 
IPCS/WHO, 1995). TBBPA has additional uses as a plasticizer and as an intermediate in the 
production of other flame retardants (IPCS/WHO, 1995; HSBD, 2001, Gain, 1997). It has 
been found in commercial drinking water (Peterman et al., 2000) and in seafood (IPCS/
WHO, 1995). TBBPA is found in human blood samples at levels of approximately 0.24 to 
4.5 ng/g lipid which converts to about 0.002–0.034 nM, (Hagmar et al., 2000; Nagayama et 
al., 2001; Thomsen et al., 2002) indicating that a certain fraction of TBBPA accumulates in 
the body despite the fact that it appears to be eliminated to some extent from the human 
system (Schauer et al., 2006). HBCD is used as a flame retardant in polystyrene foams that 
are used as thermal insulation (Kajiwara et al. 2009). Upholstery materials such as those 
used in furniture and draperies are also treated with HBCD to reduce flammability (Kajiwara 
et al. 2009). It is not chemically bound to treated materials and thus can easily leach from 
their surface (de Wit, 2002). HBCD is found in dust particles in the air (Abdallah et al., 
2008) and bioaccumulates in the food chain (Covaci et al., 2006). It has been detected in 
marine life (Peck et al., 2008) and bird eggs (Bustnes et al., 2007; Janak et al., 2008; Polder 
et al., 2008). Humans are exposed to HBCD through inhalation and diet (Abdallah et al., 
2008; Knutsen et al., 2008; van Leeuwen et al., 2008). Due to these routes of exposure 
HBCD levels of 200 pg/g serum, which is approximately 0.3 nM, are found in human blood 
(Covaci et al., 2006; Knutsen et al., 2008). It is also found in human adipose tissue 
(Pulkrabova et al., 2009), and breast milk (Kakimoto et al., 2008; Thomsen et al., 2005; 
Thomsen et al., 2003).
There are limited studies on the toxicological effects of HBCD and TBBPA on humans 
(Hinkson and Whalen, 2009; Hinkson and Whalen, 2010; Kibakaya et al., 2009). However 
there have been studies on lab animals. van der Ven et al found when rats were exposed to 
HBCD, there was an increase in liver and pituitary weight, and also increased levels of 
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cholesterol (van der Ven et al., 2006). HBCD has also been shown to have neurotoxic 
effects in mice (Eriksson et al., 2006) and to increase hepatic cytochrome P450 levels in rats 
(Germer et al., 2006). TBBPA was shown to increase the activity of glutathione reductase in 
rainbow trout (Ronisz et al., 2004). In mice it has been shown to cause decreases in serum 
proteins and red blood cells as well as increases in spleen weight (IPCS/WHO, 1995). 
Administration of TBBPA to newborn rats caused polycystic kidney lesions (Fukuda et al., 
2004). Administration of TBBPA to Wistar rats showed effects on circulating thyroid 
hormone, T4, levels (Van der Ven et al., 2006). This same study showed that there were no 
effects of TBBPA exposure on the function of splenic natural killer (NK) cells in exposed 
rats or their offspring (Van der Ven et al., 2006). In vitro studies of TBBPA showed that it 
was able to compete with thyroid hormone, T4, for binding to human transthyretin (thyroid 
hormone transport protein) (Meerts et al., 2000).
Previous studies in our laboratory have shown that human NK cells exposed to HBCD or 
TPBPA exhibit significantly decreased lytic function and cell surface protein expression 
(Hinkson and Whalen, 2009; Hinkson and Whalen, 2010; Kibakaya et al., 2009; Hurd and 
Whalen, 2011). In the current study, we examine the activation states of the MAPK pathway 
in NK cells. If the functional status of this pathway were altered by either HBCD or 
TBBPA, then this could explain at least in part the loss of NK lytic function seen with 
exposure to these compounds.
Materials and Methods
Isolation of NK cells
Peripheral blood from healthy adult (male and female) donors was used for this study. Buffy 
coats (source leukocytes) obtained from Key Biologics, LLC (Memphis, TN) were used to 
prepare NK cells. Highly-purified NK cells were obtained using a rosetting procedure. Buffy 
coats were mixed with 0.8 ml of RosetteSep human NK cell enrichment antibody cocktail 
(StemCell Technologies, Vancouver, British Columbia, Canada) per 45 ml of buffy coat. 
The mixture was incubated for 20 min at room temperature (~25°C). Following the 
incubation, 7–8 ml of the mixture was layered onto 4 ml of Ficoll-Hypaque (1.077 g/ml; MP 
Biomedicals, Irvine, CA) and centrifuged at 1200 × g for 50 min. The cell layer was then 
collected and washed twice with phosphate-buffered saline (PBS; pH 7.2) and stored in 
complete media (RPMI-1640 supplemented with 10% heat-inactivated bovine calf serum 
[BCS], 2 mM L-glutamine, and 50 U penicillin G\50 µg streptomycin/ml) at 1 million 
cells/ml (Whalen et al., 2002).
Chemical preparation
TBBPA (purchased from Fisher Scientific, 97% pure) was dissolved in dimethyl sulfoxide 
(DMSO) (Sigma-Aldrich, St. Louis, MO) to yield a 100 mM stock solution. Desired 
concentrations of TBBPA were then prepared by dilution of the stock into complete media. 
The final concentration of DMSO in any of the TBBPA exposures did not exceed 0.01%.
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NK cells (at a concentration of 3 million cells/ mL) were exposed in the following ways. 1. 
TBBPA or HBCD for 10 minutes: Cells were treated with the appropriate (DMSO) control 
or 10, 5, 2.5, 1, and 0.5 µM TBBPA or HBCD for 10 min at 37°C, 5%CO2. 2. TBBPA or 
HBCD for 1 hour: Cells were treated with the appropriate control or 10, 5, 2.5, 1, and 0.5 
µM TBBPA or HBCD for 1 h at 37°C, 5%CO2. 3. TBBPA or HBCD for 6 hours: Cells were 
treated with the appropriate control or 10, 5, 2.5, 1, and 0.5 µM TBBPA or HBCD for 6 h at 
37°C, 5%CO2. Following the above incubations the cells were washed twice and then lysed 
as described below.
Cell Viability
Cell viability was determined by trypan blue exclusion. Viability was determined at each 
concentration of TBBPA or HBCD. The viability of treated cells was then compared to that 
of control cells at each length of exposure. Viability of cells treated with the compounds was 
unchanged compared to controls. Additionally, activation of caspase-3 was monitored as an 
indicator of apoptosis.
Cell Lysates
Cell lysates were made using NK cells treated as described in the cell treatment section. 
Following the above treatments, the cells were centrifuged and the cell pellets were lysed 
using 500 µL of lysis buffer (Active motif, Carlsbad, CA) per 10 million cells. The cell 
lysates were stored frozen at −80°C up to the point when they were run on SDS-PAGE. All 
controls and TBBPA or HBCD-exposed cells for a given experimental set-up (described 
above) were from an individual donor. Each of the experimental set-ups was repeated a 
minimum of three times using cells from different donors.
Western Blot
Cell lysates were run on 10% sodium dodecylsulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membrane. To analyze 
MAPKS, the PVDF was immunoblotted with antibodies to phospho-p38 (Thr180 and 
Tyr182), p38, phospho-p44/42 (Thr202/Tyr204), p44/42, phospho-JNK, JNK, and β-actin 
(Cell Signaling Technologies, Beverly, MA). For analysis of MAP2Ks, the membrane was 
blotted with antibodies to phospho-MEK, MEK, phosphor-MKK3/6, MKK3/6 and β-actin. 
Antibodies were visualized using ECL chemiluminescent detection system (Amersham, 
Piscataway, NJ) and Kodak Image Station (Kodak, Rochester, NY) or UVP imager (Upland, 
CA). To analyze for caspase 3 and cleaved caspase 3 levels, blots were probed with an 
antibody that recognizes both intact and cleaved caspase 3 (Cell Signaling Technologies). 
The density of each protein band was determined by densitometric analysis using the Kodak 
Image Station or UVP imager analysis software. The settings on the imagers were optimized 
to detect the largest possible signal range and to prevent saturation of the system. A given 
experimental set-up (as described in the cell treatment section) always had its own internal 
control. Thus, changes in protein expression were determined relative to the internal control. 
This determination provided relative quantitation by evaluating whether a given treatment 
changed expression of the specified protein relative to untreated cells. The density of each 
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protein band was normalized to β-actin to correct for small differences in protein loading 
among the lanes.
Statistical analysis
Statistical analysis of the data for western blot analyses was carried out using ANOVA 
followed by pair-wise comparison using Student’s t test. A minimum of three separate 
determinations were carried out for each experimental set-up (n≥3) and statistical 
significance was noted at p<0.05.
RESULTS
Phospho-p44/42, p44/42, phospho-p38, p38, phospho-JNK, JNK in NK Cells Exposed to 
TBBPA for 10 minutes
Figure 1A shows the levels of phospho-p44/42 and p44/42 in NK cells exposed to 10 µM – 
0.5 µM TBBPA for 10 minutes relative to control levels. There was a statistically significant 
increase (p<0.05) in the phosphorylation (activation) of p44/42 at every concentration of 
TBBPA examined. The increase in phosphorylation was nearly 6 fold at the 10 µM 
concentration (p<0.001) at 5 µM the increase was 3.5 fold (p<0.001) while the increases at 
2.5 and 1 µM were 2 fold (p<0.02). The increase seen at 0.05 µM TBBPA for 10 minutes 
was 1.5 fold (p<0.05). Small but significant increases in total p44 of about 1.2–1.3 fold were 
seen at 10 µM, 5 µM, and 2,5 µM (Figure 1A). Figure 1B shows data from a representative 
blot.
In NK cells exposed to TBBPA for 10 min, there were statistically significant increases in 
the phosphorylation of p38 at 10 µM, 5 µM, and 2.5 µM. 10 µM TBBPA caused an 
approximately 2 fold increase (p<0.01) in phosphorylation as compared to control cells, 5 
and 2.5 µM TBBPA increased phosphorylation of p38 by about 1.5 fold (p<0.05) (Figure 
2A). As was seen with p44/42, there were small but significant increases in total p38 of 
about 1.2– 1.3 fold at 10 µM, 5 µM, and 2,5 µM (p<0.05) (Figure 2A). Data from a 
representative blot is shown in Figure 2B.
NK cells exposed to TBBPA for 10 min, showed no statistically significant changes in the 
phosphorylation of total JNK levels at any of the TBBPA concentrations that were tested 
(Figure 3A). Data from a representative blot is shown in Figure 3B.
Phospho-p44/42, p44/42, phospho-p38, p38, phospho-JNK, JNK in NK Cells Exposed to 
TBBPA for 1 hour
When NK cells were treated with TBBPA for 1 h, there were no statistically significant 
changes (p>0.05) in the phosphorylation (activation) of p44/42 at any concentration of 
TBBPA examined (Figure 4A). Cells from a total of 5 donors were examined in 5 separate 
experiments. The fold change was calculated compared to control (small differences in 
protein loading were corrected for by normalizing each band to β-actin). The 10 µM 
exposure showed fold changes of 0.8, 1.0, 0.9, 3.8, and 1.2 fold. As mentioned above, when 
statistical analysis was done there was no significant change compared to control (P>0.05). 
Exposure to 5 µM TBBPA for 1 h gave a range of fold changes of 0.7–1.4 fold, and again 
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when the results from these 5 experiment using cells from 5 separate donors were combined 
there was no statistically significant change (p>0.05) in p44/42 phosphorylation compared to 
the control. All other concentrations of TBBPA also showed no statistically significant 
changes when the fold changes from 5 experiments were averaged. The same was true for 
p38 (Figure 4B). Phosphorylation of JNK was unaffected by TBBPA exposures except at 
the 2.5 µM concentration where there was a 1.8 fold over control cells (Figure 4C).
Phospho-p44/42, p44/42, phospho-p38, p38, phospho-JNK, JNK in NK Cells Exposed to 
TBBPA for 6 hours
Exposure of NK cells to 05–10 µM TBBPA for 6 hours caused no statistically significant 
changes in the phosphorylation state of any of the MAPKS. A total of 6 experiments using 
cells from 6 separate donors were carried out. The density of each protein band was 
normalized to β-actin to correct for small differences in protein loading among the lanes. As 
was described for the 1 hour data, there were a range of changes seen at each concentration 
that varied widely from one donor to the next (i.e 10 µM TBBPA caused fold changes 
ranging from 0.3–1.3 fold). Thus, when the data from all experiments was combined there 
were no statistically significant changes (p>0.05). Representative blots are shown in Figure 
5.
Phospho-p44/42, p44/42, phospho-p38, p38, phospho-JNK, JNK in NK Cells Exposed to 
HBCD for 10 minutes
Figure 6A shows the levels of phospho-p44/42 and p44/42 in NK cells exposed to 10 µM – 
0.5 µM HBCD for 10 minutes relative to control levels. There were statistically significant 
increases in the phosphorylation (activation) of p44/42 at 10, 5, and 2.5 µM. The increase in 
phosphorylation was 3 fold (p<0.01) at the 10 µM concentration, at 5 and 2.5 µM the 
increase was 1.9 fold (p<0.01 for 5 µM, p<0.03 for 2.5 µM). Figure 6B shows data from a 
representative blot.
Exposure of NK cells HBCD for 10 min caused no significant increases in the 
phosphorylation of p38. (Figure 7A). Data from a representative blot is shown in Figure 7B.
NK cells exposed to HBCD for 10 min, showed no statistically significant changes in the 
phosphorylation of total JNK levels at any of the HBCD concentrations that were tested 
(Figure 8A). Data from a representative blot is shown in Figure 8B.
Phospho-p44/42, p44/42, phospho-p38, p38, phospho-JNK, JNK in NK Cells Exposed to 
HBCD for 1 hour
Exposure of NK cells to HBCD for 1 h caused statistically significant changes in the 
phosphorylation (activation) of p44/42 at the 10 and 5 µM exposures (p<0.03) Figure 9A. 
Figure 9 B shows data from a representative blot. p38 and JNK showed no significant 
changes in phosphorylation at any of the concentrations tested. As was described for the 1 
hour and 6 h data for TBBPA, there were a range of changes seen in p38 phosphorylation at 
each HBCD concentration that varied widely from one donor (total of 4 donors tested) to the 
next (i.e 10 µM HBCD caused fold changes ranging from 0.7–1.4 fold and 5 µM HBCD 
caused fold changes ranging from 0.7–1.2 fold). Thus, when the data from all experiments 
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was combined there were no statistically significant changes (p>0.05). Representative blots 
are shown in Figure 10.
Phospho-p44/42, p44/42, phospho-p38, p38, phospho-JNK, JNK in NK Cells Exposed to 
HBCD for 6 hours
As with TBBPA, NK cells exposed to 0.5–10 µM HBCD for 6 hours exhibited no significant 
changes in the phosphorylation state of any of the MAPKS. Representative blots are shown 
in Figure 11. However, as can be seen from the representative blot there were increases in 
phosphorylation of p44/42 at the 10 µM exposure. These increases varied widely from one 
donor to the next (10-1.4 fold) and were not statistically significant due to this. Only the 10 
µM exposure showed increases in every experiment
Effects of TBBPA and HBCD exposures on the activation states of MAP2Ks, MEK1/2 and 
MKK3/6 in NK cells
Ten minute exposures of NK cells to both TBBPA and HBCD caused substantial increases 
in the activation of p44/42. Thus, we examined if the immediate upstream activator of 
p44/42, MEK1/2, showed increased phosphorylation when exposed to these compounds. 
Figure 12 shows the effects of 10 minute exposures of NK cells to TBBPA on 
phosphorylation of MEK1/2. Phosphorylation was significantly increased about 1.8 and 2.1 
fold (p<0.05) by exposures to 10 and 5 µM TBBPA. Exposure to 2.5 µM TBBPA also 
caused increased in phosphorylation of MEK in 6 out of 7 donors however the increases 
ranged rather broadly (1.1 to 3 fold) with an average increase of 1.7 fold. A ten minute 
exposure to 1 µM TBBPA also caused a statistically significant increase in phospho-MEK of 
2.6 fold (p<0.05). TBBPA was also able to activate the immediate upstream activator of 
p38, MKK3/6. There was a 1.8 fold (p<0.05) increase in MKK3/6 phosphorylation when 
cells were exposed to 10 µM TBBPA for 10 min and a 1.9 fold (p<0.05) increase with a 5 
µM exposure (Figure 13). The effects of 10 minute exposures to HBCD on the MEK1/2 are 
shown in Figure 14. Phosphorylation of MEK1/2 was significantly increased by 10 minute 
exposures to 10 and 5 µM HBCD, 1.6 and 1.7 fold respectively. We also examined the 
effects of TBBPA on the upstream activator of MEK, Raf-1, we found no significant 
activation of Raf-1 at any of the time points examined.
Effects of TBBPA and HBCD exposures on Caspase-3
Lysates treated with TBBPA for 6 h were examined for the effects of exposures to TBBPA 
on caspase-3 levels. Caspase-3 cleavage to give cleaved caspase-3 is seen when apoptosis is 
activated. Thus, although TBBPA at the levels and length of exposure tested did not increase 
the necrosis of NK cells (measured by trypan blue exclusion), it was possible that TBBPA 
could be increasing apoptosis. Cells exposed to 0.5 – 5 µM TBBPA showed no statistically 
significant (p>0.05) changes in cleaved caspase-3 or intact caspase-3 levels as compared to 
control cells. Figure 15A shows a representative blot. However, exposure to 10 µM TBBPA 
greatly diminished the levels of intact caspase-3 (by 64%) compared to control cells 
(p<0.05). Interestingly, there was no increase in cleaved caspase-3 with this exposure. These 
data indicate that apoptosis is not being activated in NK cells by any level of TBBPA after 6 
h however, 10 µM TBBPA is decreasing the levels of caspase 3 being expressed in the cell.
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Exposure of NK cells to 0.5–10 µM HBCD for 6 h caused no significant changes in the 
expression of either intact or cleaved caspase-3 as compared to the control cells. This 
indicated that HBCD was not activating apoptosis in NK cells over the time period that we 
studied. Figure 15B shows a representative blot.
Discussion
TBBPA and HBCD are two of the many chemicals known to contaminate the environment 
that are found in human tissues (Thornton et al. 2002; Sellstroem and Jansson, 1995) 
including human blood (Hagmar et al., 2000; Nagayama et al., 2001; Thomsen et al., 2002; 
Covaci et al., 2006; Knutsen et al., 2008; Pulkrabova et al., 2009; Kakimoto et al., 2008; 
Thomsen et al., 2005; Thomsen et al., 2003). NK cells are an essential component of the 
innate immune system providing protection from tumor and virally infected cells. When NK 
function is decreased in mice, it results in increased tumor formation (Wilson et al., 2001). 
Humans with defective NK cells have been shown to have an increased risk of developing 
certain tumors (Ortaldo et al., 1992) and individuals with absent or compromised NK 
lymphocytes experienced severe herpes virus and Epstein-Barr virus infections (Biron et al., 
1989; Fleisher, et al., 1982). Compromise of NK cell function by chemical contaminant 
exposure could then lead to increased risk of both tumor development as well as viral 
infection as evidenced by decreased NK cell function resulting in increased tumor 
metastases in mice exposed to cigarette smoke (Lu et al., 2007). Additionally, exposure of 
mice to the chemical urethane causes tumors and has been shown to suppress NK function 
(Luebke et al., 1986). We have previously shown that exposures to TBBPA and HBCD 
inhibit the ability of human NK cells to bind and lyse tumor cells as well as decreasing 
expression of several cell surface proteins necessary for NK lytic function (Kibakaya et al., 
2009; Hinkson and Whalen, 2009; Hinkson and Whalen, 2010; Hurd and Whalen, 2011). A 
brief (1 h) exposure to either TBBPA or HBCD (10-0.5 µM) followed by removal of the 
compound resulted in persistent loss of NK lytic function (Hinkson and Whalen, 2009; 
Kibakaya et al., 2009). Thus, a process was stimulated within 1 h of these exposures that 
caused sustained loss of NK lytic function. Based on these data it was hypothesized that a 
component of the lytic signaling pathway may be being activated by these compounds, 
which then resulted in persistent loss of NK lytic function. Activation of p44/42 is a 
necessary signal in the NK lytic pathway, whose activation occurs within a few minutes of 
exposure to targets (Trotta et al., 1998). Thus, we examined the effects of the compound at 
10 minutes to see if such an early activation of p44/42 might be occurring. Longer 
incubations of 1 h and 6 h were also carried out to examine the length of any consistent 
activation of p44/42. The choice of exposure conditions was based on past studies including 
those where we examined the effect of other compounds known to inhibit NK lytic function 
on MAPK activation (Trotta et al., 1998; Aluoch and Whalen, 2005; Aluoch et al., 2006; 
Odman-Ghazi et al., 2010; Taylor and Whalen, 2011.) Those studies showed that the 
environmental contaminants tributyltin (TBT), dibutyltin (DBT), and ziram inhibit NK lytic 
function and cell surface-protein expression while altering the activation state of MAPK 
pathway components (Aluoch and Whalen, 2005; Aluoch et al., 2006; Odman-Ghazi et al., 
2010; Taylor and Whalen, 2011).
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Both TBBPA and HBCD caused activation of the MAPK p44/42 (ERK1/2). Activation of 
p44/42 was seen at concentrations of 2.5, 5, and 10 µM HBCD within 10 minutes. TBBPA 
caused a very robust activation of nearly 6 fold (above control) at 10 µM and induced 
smaller but still significant activations at all concentrations tested. Studies have shown that 
activation of p44/42 is necessary for NK-mediated destruction of tumor cells (Trotta et al., 
1998; Vivier et al., 2004). Those studies showed that inhibition of the p44/42 pathway by 
the MEK inhibitor PD98059 blocked NK cell mediated destruction of tumor cells as well as 
target stimulation of interferon gamma (IFNγ) synthesis. Additionally, we have previously 
shown that activation of p44/42 in NK cells by phorbol 12 myristate 13 acetate (PMA) prior 
to their contact with target cells rendered the NK cell unable to lyse the target cells 
(Dudimah et al., 2010a). This loss of function was seen within an hour of p44/42 activation 
(Dudimah, et al., 2010a). Decreased expression of cell surface proteins involved in the 
cytotoxic process was also seen following activation of p44/42 by PMA (Dudimah et al., 
2010b). Both TBBPA and HBCD were able to activate p44/42 and we have shown 
previously that activation of p44/42 decreases NK lytic function (Dudimah et al., 2010a). 
Thus, activation of this pathway appears to part of the mechanism by which these flame 
retardants diminish NK function. p44/42 activation is part of the lytic response signaling 
pathway (Vivier et al., 2004), thus if this signal is activated aberrantly by the flame retardant 
molecule then the cell will undergo changes that are consistent with having encountered and 
killed a tumor cell. It has been shown that once an NK cell has activated the lytic pathway it 
becomes inactivated to future encounters with tumor cells (Shenoy et al. 1993) Thus, the NK 
cell exposed to the flame retardants would be unresponsive to a subsequent encounter with 
an appropriate target cell, such as a tumor cell. These results are consistent with the fact that 
when NK cells exposed to either TBBPA or HBCD demonstrate marked inhibition of their 
ability to destroy tumor target cells (Kibakaya et al., 2009; Hinkson and Whalen, 2009).
The immediate upstream activator of p44/42, MEK, was also activated by TBBPA and 
HBCD. However no significant activation of Raf-1, the activator of MEK, was seen with 
these same exposures. A possible reason for this result was that our initial measurement was 
at 10 min and that activation of the MAP3K may no longer be detectable at that time point 
as turn-off processes may have already ensued.
TBBPA was also able to activate the p38 MAPK. Activation of p38 occurred after 10 
minute exposures to 2.5, 5, and 10 µM TBBPA. HBCD did not activate p38. The MAP2K 
for p38 MKK3/6 was also activated by exposure to TBBPA.
The effects of TBBPA and HBCD on MAPK activation appear to occur rapidly. The effects 
of the compounds on MAPK phosphorylation were no longer consistently measurable after 
1h. This too is consistent previous studies (Trotta et al., 1998; Aluoch and Whalen, 2005; 
Aluoch et al., 2006; Odman-Ghazi et al., 2010; Taylor and Whalen, 2011). Longer term 
consequences of this early activation would result in a number of cellular changes, which 
could include the types of effects on lytic function and protein expression that were 
described in previous studies (Hinkson and Whalen, 2009; Hinkson and Whalen, 2010; 
Kibakaya et al., 2009; Hurd and Whalen, 2011). Additionally, in the current study we saw a 
striking down regulation of caspase-3 protein levels in NK cells exposed to 10 µM TBBPA. 
This level of TBBPA also caused the greatest average activation (6 fold) of p44/42 after 10 
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min of exposure. Activation of p44/42 appears to be anti-apoptotic in many cells (Lu and 
Xu, 2006) and one study suggested that p44/42 activation may decrease caspase-3 levels 
(Xu et al., 2014). Further studies of effects of these compounds on caspase-3 expression are 
warranted.
In summary, the brominated flame retardants TBBPA and HBCD activated the MAPK 
p44/42 within 10 minutes. This activation appears to be an early part of the process by 
which these compounds diminish the lytic function of NK cells. Activation of p44/42 by 
both TBBPA and HBCD is at least in part due to the activation of the immediate upstream 
activator of p44/42. MEK1/2. TBBPA, and not HBCD, is able to activate the MAPK p38 
within 10 minutes. This activation is also due to the activation of the immediate upstream 
activator of p38, MKK3/6. Alterations of these key signaling components in NK cells by 
exposures to TBBPA and HBCD may, at least in part, explain their negative effects on NK 
function.
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Figure 1. Effects of 10 minute exposures to 10- 0.5 µM TBBPA on phospho-p44/42 and total 
p44/42 in NK cells
A) levels of phospho-p44/42 and total p44/42 normalized to control in pure NK. Values are 
mean ± S.D. from 8 separate experiments using cells from 8 different donors. * indicates 
significant difference compared to the control (p<0.05). The density of each protein band 
was normalized to β-actin to correct for small differences in protein loading among the 
lanes. B) Blot from a representative experiment.
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Figure 2. Effects of 10 minute exposures to 10-0.5 µM TBBPA on phospho-p38 and total p38 in 
NK cells
A) levels of phospho-p38 and total p38 normalized to control in pure NK. Values are mean 
± S.D. from 8 separate experiments using cells from 8 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
Figure 1. B) Blot from a representative experiment.
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Figure 3. Effects of 10 minute exposures to 10-0.5 µM TBBPA on phospho-JNK and total JNK in 
NK cells
A) levels of phospho-JNK and total JNK normalized to control in pure NK. Values are mean 
± S.D. from 8 separate experiments using cells from 8 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
Figure 1. B) Blot from a representative experiment.
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Figure 4. Effects of 1 hour exposures to 10-0.5 µM TBBPA on phospho-p44/42, p44/42, phospho-
p38, p38, phospho-JNK, and JNK in NK cells
A) representative blot of levels of phospho-p44/42 and total p44/42. B) representative blot 
of levels of phospho-p38 and total p38. C) representative blot of levels of phospho-JNK and 
total JNK. 5 separate experiments using cells from 5 different donors were carried out.
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Figure 5. Effects of 6 hour exposures to 10-0.5 µM TBBPA on phospho-p38, p38, phospho-JNK, 
and JNK in NK cells
A) representative blot of levels of phospho-p44/42 and total p44/42. B) representative blot 
of levels of phospho-p38 and total p38. C) representative blot of levels of phospho-JNK and 
total JNK. 6 separate experiments using cells from 6 different donors were carried out.
Cato et al. Page 18






















Figure 6. Effects of 10 minute exposures to 10- 0.5 µM HBCD on phospho-p44/42 and total 
p44/42 in NK cells
A) levels of phospho-p44/42 and total p44/42 normalized to control in pure NK. Values are 
mean ± S.D. from 5 separate experiments using cells from 5 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
Figure 1. B) Blot from a representative experiment.
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Figure 7. Effects of 10 minute exposures to 10-0.5 µM HBCD on phospho-p38 and total p38 in 
NK cells
A) levels of phospho-p38 and total p38 normalized to control in pure NK. Values are mean 
± S.D. from 5 separate experiments using cells from 5 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
Figure 1. B) Blot from a representative experiment.
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Figure 8. Effects of 10 minute exposures to 10-0.5 µM HBCD on phospho-JNK and total JNK in 
NK cells
A) levels of phospho-JNK and total JNK normalized to control in pure NK. Values are mean 
± S.D. from 5 separate experiments using cells from 5 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
Figure 1. B) Blot from a representative experiment.
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Figure 9. Effects of 1 h exposures to 10- 0.5 µM HBCD on phospho-p44/42 and total p44/42 in 
NK cells
A) levels of phospho-p44/42 and total p44/42 normalized to control in pure NK. Values are 
mean ± S.D. from 4 separate experiments using cells from 4 different donors. * indicates 
significant difference compared to the control (p<0.05). β-actin levels were determined for 
each condition to verify that equal amounts of protein were loaded. In addition, the density 
of each protein band was normalized to β-actin to correct for small differences in protein 
loading among the lanes. B) Blot from a representative experiment.
Cato et al. Page 22






















Figure 10. Effects of 1 hour exposures to 10-0.5 µM HBCD on phospho-p38, p38, phospho-JNK, 
and JNK in NK cells
A) representative blot of levels of phospho-p38 and total p38. B) representative blot of 
levels of phospho-JNK and total JNK. 4 separate experiments using cells from 4 different 
donors were carried out.
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Figure 11. Effects of 6 hour exposures to 10-0.5 µM HBCD on phospho-p44/42, p44/42, phospho-
p38, p38, phospho-JNK, and JNK in NK cells
A) representative blot of levels of phospho-p44/42 and total p44/42. B) representative blot 
of levels of phospho-p38 and total p38. C) representative blot of levels of phospho-JNK and 
total JNK. 4 separate experiments using cells from 4 different donors were carried out.
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Figure 12. Effects of 10 minute exposures to 10- 0.5 µM TBBPA on phospho-MEK1/2 and total 
MEK1/2 in NK cells
A) levels of phospho-MEK1/2 and total MEK normalized to control in pure NK. Values are 
mean ± S.D. from 7 separate experiments using cells from 7 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
figure 1. B) Blot from a representative experiment.
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Figure 13. Effects of 10 minute exposures to 10- 0.5 µM TBBPA on phospho-MKK3/6 and total 
MKK3/6 in NK cells
A) levels of phospho-MKK3/6 and total MKK3/6 normalized to control in pure NK. Values 
are mean ± S.D. from 5 separate experiments using cells from 5 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
figure 1. B) Blot from a representative experiment.
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Figure 14. Effects of 10 minute exposures to 10- 0.5 µM HBCD on phospho-MEK1/2 and total 
MEK1/2 in NK cells
A) levels of phospho-MEK1/2 and total MEK normalized to control in pure NK. Values are 
mean ± S.D. from 4 separate experiments using cells from 4 different donors. * indicates 
significant difference compared to the control (p<0.05). Data was treated as described in 
figure 1. B) Blot from a representative experiment.
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Figure 15. Effects of 6 hour exposures to 10-0.5 µM TBBPA and HBCD on Caspase-3 levels
A) representative blot of levels of the effects of TBBPA exposures on Caspase-3 and 
cleaved Caspase-3. B) representative blot of levels of the effects of HBCD exposures on 
Caspase-3 and cleaved Caspase-3. 3 separate experiments using cells from 3 different 
donors were carried out.
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